English (international)
Eesti
Български
Deutsch
Français
Español (Latinoamérica)
Polski
Magyar
Română
Lonza Group AG
Geschlossen
552 -0.29
Übersicht
Veränderung der Aktienkurses
24h
Min
551.4
Max
556
Einkommen | 244M |
|---|---|
Verkäufe | -582M 3.1B |
KGV Branchendurchschnitt | 26.67 |
EPS | 4.61 |
Gewinnspanne | 6.705 |
Marktkapitalisierung | -144M 40B |
|---|---|
Vorheriger Eröffnungskurs | 552.29 |
Vorheriger Schlusskurs | 552 |
Nachrichtenstimmung
By Acuity
100%
0%
Lonza Group AG Chart
Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.
Ähnliche Nachrichten
Lonza Group AG Prognose
Stimmung
By Acuity
Nachrichtenstimmung
Sehr starke bärische Evidenz
Volatilität
Unterdurchschnittlich
Nachrichtenvolumen (RCV)
Überdurchschnittlich
Finanzen
Betriebsaufwand
Gewinn vor Steuern
Verkäufe
Umsatzkosten
Bruttogewinn aus dem Verkauf
Zinsaufwand für Schulden
EBITDA
Betriebsergebnis
$
Über Lonza Group AG
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.